Amylyx Pharmaceuticals (AMLX)
(Delayed Data from NSDQ)
$2.16 USD
-0.06 (-2.70%)
Updated Sep 3, 2024 04:00 PM ET
5-Strong Sell of 5 5
F Value C Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 39% (99 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.71 | 1.58 | 9.99 |
Current Quarter Estimate | -0.47 | -1.22 | 61.00 |
Year Ago Quarter Estimate | 0.30 | -0.07 | 54.84 |
Next Quarter Estimate | -0.49 | -1.93 | 63.00 |
Next Year Estimate | -1.58 | 12.53 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -650.00 | 20.30 | 15.67 |
Next Year | 58.96 | 15.10 | 11.34 |
Last 5 Years | NA | 7.90 | 8.10 |
Next 5 Years | 65.00 | 21.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -3.93 |
Price/Book (MRQ) | 0.56 | 1.59 |
Price/Cash Flow (MRFY) | 3.61 | 9.36 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -17.86% | -61.35% |
Return on Equity (TTM) | -15.51% | -58.93% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.